Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusiness

Cipla launches skin treatment drug in US

According to IQVIA Health, Cubicin injection brand and generics had sales of around USD 606 million for the most recent 12 months ending in June 2019.

September 25, 2019 / 10:04 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Cipla on Wednesday said it has launched Daptomycin Injection, used for treating complicated skin infections, in the US market. Daptomycin Injection is generic version of Cubicin, Cipla said in a statement.

"Cipla and its subsidiary Cipla USA, Inc announce the launch of Daptomycin for Injection, 500mg/vial, single-dose vial, AP-rated generic equivalent of Cubicin for Injection in the US," the statement said.

According to IQVIA Health, Cubicin injection brand and generics had sales of around USD 606 million for the most recent 12 months ending in June 2019.

"The product is available for shipping immediately," the statement said.

PTI
first published: Sep 25, 2019 10:02 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347